Opioid Overdose Mortality Among Former North Carolina Inmates: 2000-2015

American Journal of Public Health
Shabbar I RanapurwalaStephen W Marshall

Abstract

To examine differences in rates of opioid overdose death (OOD) between former North Carolina (NC) inmates and NC residents and evaluate factors associated with postrelease OOD. We linked NC inmate release data to NC death records, calculated OOD standardized mortality ratios to compare former inmates with NC residents, and calculated hazard ratios to identify predictors of time to OOD. Of the 229 274 former inmates released during 2000 to 2015, 1329 died from OOD after release. At 2-weeks, 1-year, and complete follow-up after release, the respective OOD risk among former inmates was 40 (95% confidence interval [CI] = 30, 51), 11 (95% CI = 9.5, 12), and 8.3 (95% CI = 7.8, 8.7) times as high as general NC residents; the corresponding heroin overdose death risk among former inmates was 74 (95% CI = 43, 106), 18 (95% CI = 15, 21), and 14 (95% CI = 13, 16) times as high as general NC residents, respectively. Former inmates at greatest OOD risk were those within the first 2 weeks after release, aged 26 to 50 years, male, White, with more than 2 previous prison terms, and who received in-prison mental health and substance abuse treatment. Former inmates are highly vulnerable to opioids and need urgent prevention measures.

References

Dec 13, 2006·International Journal of Epidemiology·A KariminiaM G Law
Jan 12, 2007·The New England Journal of Medicine·Ingrid A BinswangerThomas D Koepsell
Mar 27, 2007·Journal of Substance Abuse Treatment·Faye S TaxmanLana D Harrison
Aug 2, 2007·European Journal of Epidemiology·Azar KariminiaLuke Grant
Oct 17, 2008·American Journal of Public Health·David L RosenDavid A Wohl
Feb 25, 2009·The American Journal of Forensic Medicine and Pathology·Clarissa S KrinskyKurt B Nolte
Jun 29, 2010·Addiction·Elizabeth L C MerrallSheila M Bird
Oct 5, 2010·Public Health·L F MøllerA Gatherer
Jan 18, 2011·American Journal of Epidemiology·Anne C SpauldingN Kyle Steenland
Jul 9, 2011·Annals of Epidemiology·David L RosenVictor J Schoenbach
Jun 5, 2012·Drug and Alcohol Dependence·Stuart A KinnerM-J Milloy
Dec 1, 2012·Journal of Health and Social Behavior·Jason SchnittkerChristopher Uggen
Oct 30, 2016·Drug and Alcohol Dependence·R J WinterS A Kinner
Dec 30, 2016·MMWR. Morbidity and Mortality Weekly Report·Rose A RuddLawrence Scholl
Mar 17, 2017·International Journal of Prisoner Health·Lauren Brinkley-RubinsteinJosiah Rich
Apr 14, 2017·Lancet·Christopher Wildeman, Emily A Wang
Jul 19, 2017·The American Journal of Emergency Medicine·Travis D OlivesJon B Cole

❮ Previous
Next ❯

Citations

Nov 7, 2019·Journal of Addiction Medicine·David L Rosenbloom, David C Lewis
Feb 6, 2020·Journal of Addiction Medicine·Anees BahjiHeather Stuart
Jan 1, 2019·American Journal of Public Health·Jean-Paul R SoucyMaida J Sewitch
Mar 28, 2020·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Rachel Feuerstein-SimonCarolyn C Cannuscio
Oct 5, 2019·JAMA Network Open·Lauren Brinkley-RubinsteinShabbar I Ranapurwala
Oct 14, 2020·Addiction·Wen Qi GanAmanda K Slaunwhite
Oct 20, 2020·Drug and Alcohol Dependence·Redonna K ChandlerNora D Volkow
Sep 30, 2020·Drug and Alcohol Dependence·Gary A ZarkinRobert P Schwartz
Jun 14, 2019·Preventive Medicine Reports·Alyssa M PeckhamNicole K Early
Nov 23, 2020·Journal of Substance Abuse Treatment·Melissa J ZielinskiChelsey E Bull
Feb 10, 2021·The International Journal on Drug Policy·Laura McKendyLeslie Anne Keown
Feb 19, 2021·Journal of General Internal Medicine·Robert A Kleinman, Nathaniel P Morris
Feb 23, 2021·Journal of Addictive Diseases·James R Latronica
Feb 24, 2021·Substance Abuse Treatment, Prevention, and Policy·Christine E GrellaDennis P Watson
Mar 21, 2021·Journal of Substance Abuse Treatment·Rosemarie A MartinLauren Brinkley-Rubinstein
Jul 26, 2021·Health & Justice·Christy K ScottJohn Carnevale
Dec 29, 2021·International Journal of Prisoner Health·Linsey Ann Belisle, Elia Del Carmen Solano-Patricio
Jan 27, 2022·American Journal of Public Health·Shabbar I RanapurwalaScott K Proescholdbell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.